NDC 0002-3270-01 - Cymbalta

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0002-3270
Requested NDC: 0002-3270-01
Package NDCs from labels: 0002-3270-30, 0002-3270-01
Manufacturer: Eli Lilly and Company
Effective date: 2025-07-21
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Cymbalta - Eli Lilly and Company	Eli Lilly and Company	2025-07-21	HUMAN PRESCRIPTION DRUG LABEL
Cymbalta - PD-Rx Pharmaceuticals, Inc.	PD-Rx Pharmaceuticals, Inc.	2022-02-17	HUMAN PRESCRIPTION DRUG LABEL
Cymbalta	H.J. Harkins Company, Inc. \| Eli Lilly and Company \| Evonik Degussa Corporation \| Lilly del Caribe, Inc. (PR06) \| Lilly del Caribe, Inc. (PR01) \| Eli Lilly and Company (Indianapolis) \| Sharp - Conshohocken \| Sharp - Allentown	2011-10-18	HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unit	National Council for Prescription Drug Programs	2012-07-24	Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0002-3270-30	Cymbalta	30 in 1 BOTTLE	CAPSULE, DELAYED RELEASE	30		90

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0002-3270	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	89	Legacy NDC, 1 package rows	20241206_2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0002-3270-01	EA - Each	0002-3270	7149c6ef-ec54-4fd3-9083-2e15125bea62	1	2012-07-24
0002-3270-04	EA - Each	0002-3270	ad73f24c-7d72-4830-97ae-1a9ba1b8ec58	1	2012-07-24
0002-3270-30	EA - Each	0002-3270	581237c9-1b60-4246-8dff-bfaab7eb8898	1	2012-07-24
0002-3270-33	EA - Each	0002-3270	9366b8c5-1181-45d4-8587-e383e34e2a45	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Duloxetine hydrochloride	ACTIVE INGREDIENT	9044SC542W	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
Duloxetine	ACTIVE MOIETY	O5TNM5N07U	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
Gelatin	INACTIVE INGREDIENT	2G86QN327L	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MM2/S)	INACTIVE INGREDIENT	24P2YXD2PW	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
Hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
Sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
Sucrose	INACTIVE INGREDIENT	C151H8M554	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
Talc	INACTIVE INGREDIENT	7SEV7J4R1U	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
Triethyl citrate	INACTIVE INGREDIENT	8Z96QXD6UM	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [ELI LILLY AND COMPANY]	66
Duloxetine hydrochloride	ACTIVE INGREDIENT	9044SC542W	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
Duloxetine	ACTIVE MOIETY	O5TNM5N07U	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
Gelatin	INACTIVE INGREDIENT	2G86QN327L	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MM2/S)	INACTIVE INGREDIENT	24P2YXD2PW	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
Hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
Sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
Sucrose	INACTIVE INGREDIENT	C151H8M554	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
Talc	INACTIVE INGREDIENT	7SEV7J4R1U	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
Triethyl citrate	INACTIVE INGREDIENT	8Z96QXD6UM	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]	45
Duloxetine hydrochloride	ACTIVE INGREDIENT	9044SC542W	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
Duloxetine	ACTIVE MOIETY	O5TNM5N07U	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
Gelatin	INACTIVE INGREDIENT	2G86QN327L	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MM2/S)	INACTIVE INGREDIENT	24P2YXD2PW	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
Hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
Sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
Sucrose	INACTIVE INGREDIENT	C151H8M554	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
Talc	INACTIVE INGREDIENT	7SEV7J4R1U	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1
Triethyl citrate	INACTIVE INGREDIENT	8Z96QXD6UM	CYMBALTA (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 61 of 110 · 2,199 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dolce and Gabbana Everlast Foundation SPF 20 30N Medium Deep	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	37188b77-ab0b-4bea-b839-99e589600a2b	2025-08-11	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 31N Medium Deep	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	c89e45d6-2322-4913-a557-e1780a86fd63	2025-08-11	Warnings	Exact identifier unii: 15FIX9V2JP
Duloxetine	DULOXETINE	Ascend Laboratories, LLC	e6477c41-97a2-45a7-94b5-487aa65199f6	2025-08-11	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 596926 rxcui: 596930 rxcui: 596934 unii: 9044SC542W
SUNSCREEN SPF50	ETHYLHEXYL METHOXYCINNAMATE, OCTOCRYLENE, TITANIUM DIOXIDE	Guangzhou Tinsun Biotechnology Company Limited	3bc1c6e9-1dd5-d7c6-e063-6394a90ad89e	2025-08-07	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 17W Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	053cb3cd-dd16-4d08-b347-a4349fa37c07	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 14W Light Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	7bf90657-b636-41d6-b96c-88d174989f5b	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 15N Light Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	da7e19cd-6a8b-47df-bfc9-2f0f11b7955c	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 16N Light Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	f7a1d379-6de0-4be4-84a9-e0ebef332bef	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 18N Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	671be8a6-51b7-45d2-9fff-c7736d2eea3e	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 19W Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	9efa5db5-d774-4089-895c-9667eda0f11b	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 20C Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	76232666-e23f-4842-bd0d-37819739ec3a	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 21W Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	876b9a5d-dae3-47f1-9da6-b5e179fd28cd	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
UV SOLUTIONS BRIGHTENING TINTED BROAD SPECTRUM SPF 50 SUNSCREEN NIACINAMIDE ANTIOXIDANTS	TITANIUM DIOXIDE AND ZINC OXIDE	CLINIQUE LABORATORIES LLC	3bba70e9-da29-f43b-e063-6294a90a08ef	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
NAKED SUNDAYS CABANA GLOW MINERAL GLOW SERUM DROPS PEARL 40mL with Pink Algae SPF 50	TITANIUM OXIDE, ZINC OXIDE	NAKED SUNDAYS PTY LTD	0127f290-8c5e-4285-e063-6294a90ae128	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
GR BB SPF 25	OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	3b22579b-21ce-4b96-bd24-774ce35bf6f7	2025-08-06	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 08W Light	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	498bf941-67f2-41d5-a039-9f827b68297e	2025-08-05	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 10N Light Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	54e390bd-b84a-4c43-986e-74923e34689d	2025-08-05	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 09C Light Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	897024cd-576e-4a8e-8daa-92dc3bb4b3a5	2025-08-05	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 11W Light Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	303967d1-9df8-4a8e-a264-6b0d8fdbf2a8	2025-08-05	Warnings	Exact identifier unii: 15FIX9V2JP
Dolce and Gabbana Everlast Foundation SPF 20 12N Light Medium	OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	26062cd7-3817-46c7-b65f-92cd57eca5dd	2025-08-05	Warnings	Exact identifier unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.